title: Rethinking CNS disorders: time for new drug targets?
authors.affiliation: ZENEREI Institute, 309 Palmer Court, Slidell, LA 70458, USA; Research Institute for Marine Drugs and Nutrition, Guangdong Ocean University, Zhanjiang, Guangdong 524025, China. Electronic address: avkalueff@gmail.com.
authors.forename: Allan V
authors.initials: AV
authors.lastname: Kalueff
authors.affiliation: ZENEREI Institute, 309 Palmer Court, Slidell, LA 70458, USA; Department of Neuroscience, University of Pittsburgh, A210 Langley Hall, Pittsburgh, PA 15260, USA.
authors.forename: Adam Michael
authors.initials: AM
authors.lastname: Stewart
authors.affiliation: Department of Psychology, University of Minnesota, Elliot Hall, Minneapolis, MN 55455, USA.
authors.forename: Irving I
authors.initials: II
authors.lastname: Gottesman
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D058990:Molecular Targeted Therapy